Health Care
Price
$94.37
+2.59%Market Cap
$54.34B
Day High
$94.47
Day Low
$91.82
Edwards Lifesciences delivered strong Q1 FY2026 revenue growth of 16.7% to $1.65B, with operating income surging 21.0%, though operating cash flow dropped sharply by 84.4% to $43.8M amid aggressive share buybacks of $421.8M.
Key risk: Dramatic Operating Cash Flow Decline
Operating cash flow fell 84.4% YoY to just $43.8M in Q1 FY2026 from $280.4M, a significant deterioration that may reflect working capital build-up or timing of payments. Sustained weakness in cash generation could limit financial flexibility despite strong reported earnings.
Other Health Care Equipment companies